ertapenem has been researched along with Koch's Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arthur, M; Braud, E; Compain, F; Dubée, V; Etheve-Quelquejeu, M; Fonvielle, M; Hugonnet, JE; Iannazzo, L; Mainardi, JL; Soroka, D; Triboulet, S | 1 |
| Drobniewski, F; Gonzalo, X; McHugh, TD; Ortiz Canseco, J; Satta, G | 1 |
2 other study(ies) available for ertapenem and Koch's Disease
| Article | Year |
|---|---|
Routes of Synthesis of Carbapenems for Optimizing Both the Inactivation of L,D-Transpeptidase LdtMt1 of Mycobacterium tuberculosis and the Stability toward Hydrolysis by β-Lactamase BlaC.
Topics: Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Humans; Hydrolysis; Kinetics; Mycobacterium tuberculosis; Peptidyl Transferases; Tuberculosis | 2016 |
Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution.
Topics: Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2020 |